intoDNA at the APM Annual Conference in Philadelphia
We are pleased to announce that intoDNA is sponsoring the 2nd Annual Advancing Precision Medicine Conference in Philadelphia on October 3–4, 2025. (APM website)
Our Founder and CEO, Magda Kordon-Kiszala, will deliver a presentation on Saturday, October 4 at 12:30 PM ET, titled:
“dSTRIDE™-HR: A Functional Biomarker for In Situ, ‘real-time’ Detection and Quantification of Homologous Recombination Activity.”
In her talk, Magda will highlight how STRIDE™ technology enables the development of functional precision biomarkers and supports progress in targeted oncology drug discovery.
We look forward to connecting with the precision medicine community in Philadelphia and sharing how intoDNA is helping to accelerate the future of biomarker innovation.